Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey

[1]  V. Salomaa,et al.  The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study. , 2010, Diabetes & metabolism.

[2]  L. Luzi,et al.  Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.

[3]  F. Paccaud,et al.  Metabolically healthy obesity: different prevalences using different criteria , 2010, European Journal of Clinical Nutrition.

[4]  Veikko Salomaa,et al.  Thirty-five-year trends in cardiovascular risk factors in Finland. , 2010, International journal of epidemiology.

[5]  G. Marchesini,et al.  Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity , 2010, Obesity surgery.

[6]  A. Rissanen,et al.  Twenty‐year changes in the prevalence of obesity among Finnish adults , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[7]  M. Blüher.  The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals , 2010, Current opinion in lipidology.

[8]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[9]  J. Boer,et al.  Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20 000 Dutch men and women aged 20–65 years , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[10]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[11]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[12]  Cliona O'Farrelly,et al.  Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient? , 2009, Obesity.

[13]  J. Tuomilehto,et al.  High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population , 2008, BMC public health.

[14]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) , 2008 .

[15]  C. Aguilar-Salinas,et al.  High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.

[17]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[18]  R. Rabasa-Lhoret,et al.  Metabolically healthy but obese women: effect of an energy-restricted diet , 2008, Diabetologia.

[19]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[20]  A. Kotronen,et al.  Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Sirkka Keinänen-Kiukaanniemi,et al.  National type 2 diabetes prevention programme in Finland: FIN-D2D , 2007, International journal of circumpolar health.

[22]  F. Conus,et al.  Characteristics of metabolically obese normal-weight (MONW) subjects. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[23]  Ralph B D'Agostino,et al.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[25]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  G. Dagenais,et al.  Insulin resistance syndrome, body mass index and the risk of ischemic heart disease , 2005, Canadian Medical Association Journal.

[27]  A. Karelis,et al.  Clinical markers for the identification of metabolically healthy but obese individuals , 2004, Diabetes, obesity & metabolism.

[28]  Remi Rabasa-Lhoret,et al.  Metabolic and body composition factors in subgroups of obesity: what do we know? , 2004, The Journal of clinical endocrinology and metabolism.

[29]  V. Salomaa,et al.  Trends in fatal and non‐fatal coronary heart disease events in Finland during 1991–2001 , 2004, Scandinavian cardiovascular journal : SCJ.

[30]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[31]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[32]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[33]  E. A. Sims,et al.  Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.

[34]  E. A. Sims,et al.  What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? , 2001, The Journal of clinical endocrinology and metabolism.

[35]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[36]  D. Chisholm,et al.  The metabolically obese, normal-weight individual revisited. , 1998, Diabetes.

[37]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[39]  B. Gersh,et al.  Thirty-five-year trends in cardiovascular risk factors in Finland , 2011 .

[40]  R. Rabasa-Lhoret,et al.  Metabolically healthy but obese individuals: relationship with hepatic enzymes. , 2010, Metabolism: clinical and experimental.

[41]  BMC Public Health , 2007 .

[42]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[43]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .